|Bid||79.39 x 900|
|Ask||79.82 x 900|
|Day's range||79.52 - 80.98|
|52-week range||64.75 - 92.68|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||28.27|
|Earnings date||01 May 2023 - 05 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||83.45|
Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers
MedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications.
Catalent's (CTLT) latest commercial supply agreement is expected to combat the opioid epidemic by making OTC naloxone more widely and easily accessible.